Home Health News Medicare Spends Billions on Oncology Drugs Offering Little Added Benefit By News Health 4 hours Ago Share on FacebookShare on Twitter (MedPage Today) — In an analysis of Medicare’s top-selling brand-name oncology drugs, researchers found that while the vast majority provided high added therapeutic benefit, 10 were classified as providing low or no added benefit. In 2022, Medicare… Source link : https://www.medpagetoday.com/hematologyoncology/othercancers/114981 Author : Publish date : 2025-04-04 21:02:00 Copyright for syndicated content belongs to the linked Source. Categories: Health News Related Content How a home DNA test finally revealed the truth By News Health April 5, 2025 Embattled TAVR Device Myval Meets Expectations in Trial, but Trouble Still Ahead By News Health April 4, 2025 Switch to Tirzepatide in T2D More Effective Than Upping Dulaglutide Dose By News Health April 4, 2025 NIOSH Workers Wonder, 'Who Is Going to Carry on My Work?' By News Health April 4, 2025 AI data scrapers are an existential threat to Wikipedia By News Health April 4, 2025 WARRIOR Underscores Burden of Nonobstructive Angina in Women By News Health April 4, 2025